Arrowstreet Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-418,539
| Closed | -$13.8M | – | 1437 |
|
|
2021
Q3 | $13.8M | Buy |
418,539
+297,251
| +245% | +$9.8M | 0.02% | 635 |
|
|
2021
Q2 | $7.67M | Buy |
121,288
+47,888
| +65% | +$3.03M | 0.01% | 926 |
|
|
2021
Q1 | $3.15M | Buy |
+73,400
| New | +$3.15M | ﹤0.01% | 1383 |
|
|
2020
Q3 | – | Sell |
-42,087
| Closed | -$1.38M | – | 2314 |
|
|
2020
Q2 | $1.38M | Buy |
42,087
+2,900
| +7% | +$94.7K | ﹤0.01% | 1645 |
|
|
2020
Q1 | $1.05M | Sell |
39,187
-41,304
| -51% | -$1.11M | ﹤0.01% | 1302 |
|
|
2019
Q4 | $2.47M | Buy |
+80,491
| New | +$2.47M | 0.01% | 1070 |
|